Explainable artificial intelligence based on feature optimization for age at onset prediction of spinocerebellar ataxia type 3

Artificial Intelligence in the Diagnosis and Quantitative Phenotyping of Hyperkinetic Movement Disorders: A Systematic Review

Background: Hyperkinetic movement disorders involve excessive, involuntary movements such as ataxia, chorea, dystonia, myoclonus, tics, and tremor. Recent advances in artificial intelligence (AI) allow investigators to integrate multimodal instrumented movement measurements and imaging techniques and to analyze these data together at scale. In this systematic review, we aim to characterize AI's performance in diagnosing and quantitatively phenotyping these disorders. Methods: We searched PubMed and Embase using a semi-automated article-screening pipeline. Results: Fifty-five studies met the inclusion criteria (n = 11,946 subjects). Thirty-five studies used machine learning, sixteen used deep learning, and four used both. Thirty-eight studies reported disease diagnosis, twenty-three reported quantitative phenotyping, and six reported both. Diagnostic accuracy was reported in 36 of 38 and correlation coefficients in 10 of 23 studies. Kinematics (e.g., accelerometers and inertial measurement units) were the most used dataset. Diagnostic accuracy was reported in 36 studies and ranged from 56 to 100% compared to clinical diagnoses to differentiate them from healthy controls. The correlation coefficient was reported in 10 studies and ranged from 0.54 to 0.99 compared to clinical ratings for quantitative phenotyping. Five studies had an overall judgment of "low risk of bias" and three had external validation. Conclusion: There is a need to adopt AI-based research guidelines to minimize reporting heterogeneity and bolster clinical interpretability.

Novel genotype-phenotype correlations, differential cerebellar allele-specific methylation, and a common origin of the (ATTTC)n insertion in spinocerebellar ataxia type 37

Spinocerebellar ataxia subtype 37 (SCA37) is a rare disease originally identified in ataxia patients from the Iberian Peninsula with a pure cerebellar syndrome. SCA37 patients carry a pathogenic intronic (ATTTC)n repeat insertion flanked by two polymorphic (ATTTT)n repeats in the Disabled-1 (DAB1) gene leading to cerebellar dysregulation. Herein, we determine the precise configuration of the pathogenic 5'(ATTTT)n-(ATTTC)n-3'(ATTTT)n SCA37 alleles by CRISPR-Cas9 and long-read nanopore sequencing, reveal their epigenomic signatures in SCA37 lymphocytes, fibroblasts, and cerebellar samples, and establish new molecular and clinical correlations. The 5'(ATTTT)n-(ATTTC)n-3'(ATTTT)n pathogenic allele configurations revealed repeat instability and differential methylation signatures. Disease age of onset negatively correlated with the (ATTTC)n, and positively correlated with the 3'(ATTTT)n. Geographic origin and gender significantly correlated with age of onset. Furthermore, significant predictive regression models were obtained by machine learning for age of onset and disease evolution by considering gender, the (ATTTC)n, the 3'(ATTTT)n, and seven CpG positions differentially methylated in SCA37 cerebellum. A common 964-kb genomic region spanning the (ATTTC)n insertion was identified in all SCA37 patients analysed from Portugal and Spain, evidencing a common origin of the SCA37 mutation in the Iberian Peninsula originating 859 years ago (95% CI 647-1378). In conclusion, we demonstrate an accurate determination of the size and configuration of the regulatory 5'(ATTTT)n-(ATTTC)n-3'(ATTTT)n repeat tract, avoiding PCR bias amplification using CRISPR/Cas9-enrichment and nanopore long-read sequencing, resulting relevant for accurate genetic diagnosis of SCA37. Moreover, we determine novel significant genotype-phenotype correlations in SCA37 and identify differential cerebellar allele-specific methylation signatures that may underlie DAB1 pathogenic dysregulation.

Neural network system for analyzing statistical factors of patients for predicting the survival of dental implants

Implants are now the standard method of replacing missing or damaged teeth. Despite the improving technologies for the manufacture of implants and the introduction of new protocols for diagnosing, planning, and performing implant placement operations, the percentage of complications in the early postoperative period remains quite high. In this regard, there is a need to develop new methods for preliminary assessment of the patient's condition to predict the success of single implant survival. The intensive development of artificial intelligence technologies and the increase in the amount of digital information that is available for analysis make it relevant to develop systems based on neural networks for auxiliary diagnostics and forecasting. Systems based on artificial intelligence in the field of dental implantology can become one of the methods for forming a second opinion based on mathematical decision making and forecasting. The actual clinical evaluation of a particular case and further treatment are carried out by the dentist, and AI-based systems can become an integral part of additional diagnostics. The article proposes an artificial intelligence system for analyzing various patient statistics to predict the success of single implant survival. As the topology of the neural network, the most optimal linear neural network architectures were developed. The one-hot encoding method was used as a preprocessing method for statistical data. The novelty of the proposed system lies in the developed optimal neural network architecture designed to recognize the collected and digitized database of various patient factors based on the description of the case histories. The accuracy of recognition of statistical factors of patients for predicting the success of single implants in the proposed system was 94.48%. The proposed neural network system makes it possible to achieve higher recognition accuracy than similar neural network prediction systems due to the analysis of a large number of statistical factors of patients. The use of the proposed system based on artificial intelligence will allow the implantologist to pay attention to the insignificant factors affecting the quality of the installation and the further survival of the implant, and reduce the percentage of complications at all stages of treatment. However, the developed system is not a medical device and cannot independently diagnose patients. At this point, the neural network system for analyzing the statistical factors of patients can predict a positive or negative outcome of a single dental implant operation and cannot be used as a full-fledged tool for supporting medical decision-making.